778 related articles for article (PubMed ID: 25501633)
1. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.
Al Maini M; Adelowo F; Al Saleh J; Al Weshahi Y; Burmester GR; Cutolo M; Flood J; March L; McDonald-Blumer H; Pile K; Pineda C; Thorne C; Kvien TK
Clin Rheumatol; 2015 May; 34(5):819-29. PubMed ID: 25501633
[TBL] [Abstract][Full Text] [Related]
2. A global perspective on the challenges and opportunities in learning about rheumatic and musculoskeletal diseases in undergraduate medical education : White paper by the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD).
Al Maini M; Al Weshahi Y; Foster HE; Chehade MJ; Gabriel SE; Saleh JA; Al Wahshi H; Bijlsma JWJ; Cutolo M; Lakhanpal S; Venkatramana M; Pineda C; Woolf AD
Clin Rheumatol; 2020 Mar; 39(3):627-642. PubMed ID: 31127461
[TBL] [Abstract][Full Text] [Related]
3. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.
Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R
Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535
[TBL] [Abstract][Full Text] [Related]
4. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
van der Heijde D; Daikh DI; Betteridge N; Burmester GR; Hassett AL; Matteson EL; van Vollenhoven R; Lakhanpal S
Ann Rheum Dis; 2018 Jun; 77(6):829-832. PubMed ID: 29525777
[TBL] [Abstract][Full Text] [Related]
5. Mexican rheumatology: where do we stand?
Pineda C; Sandoval H; Fraga-Mouret A
Rheumatol Int; 2019 Apr; 39(4):585-593. PubMed ID: 30421102
[TBL] [Abstract][Full Text] [Related]
6. Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
van der Heijde D; Daikh DI; Betteridge N; Burmester GR; Hassett AL; Matteson EL; van Vollenhoven R; Lakhanpal S
Arthritis Rheumatol; 2018 Jun; 70(6):826-831. PubMed ID: 29532625
[TBL] [Abstract][Full Text] [Related]
7. Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre.
Reuter K; Haupt C; Molto A; Cope A; van Vollenhoven RF; Elewaut D; Lories R; McInnes IB
RMD Open; 2022 Jun; 8(2):. PubMed ID: 35714997
[TBL] [Abstract][Full Text] [Related]
8. Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management.
Simões D; Araújo FA; Severo M; Monjardino T; Cruz I; Carmona L; Lucas R
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):12-20. PubMed ID: 27482954
[TBL] [Abstract][Full Text] [Related]
9. Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake.
Loza E; Carmona L; Woolf A; Fautrel B; Courvoisier DS; Verstappen S; Aarrestad Provan S; Boonen A; Vliet Vlieland T; Marchiori F; Jasinski T; Van der Elst K; Ndosi M; Dziedzic K; Carrasco JM
Ann Rheum Dis; 2022 Oct; 81(10):1344-1347. PubMed ID: 35961760
[TBL] [Abstract][Full Text] [Related]
10. 10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UK.
Jalali-Najafabadi F; Bailey R; Lyons J; Akbari A; Ba Dhafari T; Azadbakht N; Rafferty J; Watkins A; Martin GP; Bowes J; Lyons RA; Barton A; Peek N
BMJ Open; 2024 Jun; 14(6):e079169. PubMed ID: 38904124
[TBL] [Abstract][Full Text] [Related]
11. Use of multidimensional composite scores in rheumatology: parsimony versus subtlety.
Landewé RBM; van der Heijde D
Ann Rheum Dis; 2021 Mar; 80(3):280-285. PubMed ID: 33144304
[TBL] [Abstract][Full Text] [Related]
12. Progress made towards enhancement of rheumatology education and practice in Zambia: review of an ILAR-supported project.
Chipeta J; Njobvu P; McGill PE; Bucala R
Clin Rheumatol; 2014; 33(10):1367-72. PubMed ID: 24752350
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of undiagnosed rheumatic and musculoskeletal diseases and its association with health-related quality of life and with physical function.
Pina Gonçalves N; Azeredo S; Sepriano A; Henriques AR; Pires T; Branco JC; Canhão H; Rodrigues AM
ARP Rheumatol; 2023; 2(1):7-16. PubMed ID: 36739530
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across-sectional study.
Zhang Y; Xu P; Huang J; Hu Z
Int J Rheum Dis; 2024 Apr; 27(4):e15150. PubMed ID: 38661306
[TBL] [Abstract][Full Text] [Related]
15. Rheumatology in the Middle East in 2017: clinical challenges and research.
Watad A; Al-Saleh J; Lidar M; Amital H; Shoenfeld Y
Arthritis Res Ther; 2017 Jun; 19(1):149. PubMed ID: 28666485
[TBL] [Abstract][Full Text] [Related]
16. Tackling global challenges in pediatric rheumatology.
Lewandowski LB
Curr Opin Rheumatol; 2020 Sep; 32(5):414-420. PubMed ID: 32657804
[TBL] [Abstract][Full Text] [Related]
17. EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology.
Rodrigues AM; Gouveia N; da Costa LP; Eusébio M; Ramiro S; Machado P; Mourão AF; Silva I; Laires P; Sepriano A; Araújo F; Coelho PS; Gonçalves S; Zhao A; Fonseca JE; de Almeida JM; Tavares V; da Silva JA; Barros H; Cerol J; Mendes J; Carmona L; Canhão H; Branco JC
Acta Reumatol Port; 2015; 40(2):110-24. PubMed ID: 26219965
[TBL] [Abstract][Full Text] [Related]
18. Overcoming challenges in order to improve the management of rheumatic and musculoskeletal diseases across the globe.
Woolf AD; Gabriel S
Clin Rheumatol; 2015 May; 34(5):815-7. PubMed ID: 25700667
[No Abstract] [Full Text] [Related]
19. Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons.
Putrik P; Ramiro S; Orueta JF; Keszei A; Alonso Moran E; Nuño Solinis R; Boonen A
Clin Exp Rheumatol; 2018; 36(4):589-594. PubMed ID: 29465359
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL
Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
